KR20170005806A - 신생아 마이크로바이옴 보충 - Google Patents

신생아 마이크로바이옴 보충 Download PDF

Info

Publication number
KR20170005806A
KR20170005806A KR1020167031451A KR20167031451A KR20170005806A KR 20170005806 A KR20170005806 A KR 20170005806A KR 1020167031451 A KR1020167031451 A KR 1020167031451A KR 20167031451 A KR20167031451 A KR 20167031451A KR 20170005806 A KR20170005806 A KR 20170005806A
Authority
KR
South Korea
Prior art keywords
fetus
probiotic microorganism
probiotic
oral cavity
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020167031451A
Other languages
English (en)
Korean (ko)
Inventor
보 몰리스탐
크제르스티 아가르드
Original Assignee
바이오가이아 에이비
바이오가이아 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오가이아 에이비, 바이오가이아 에이비 filed Critical 바이오가이아 에이비
Publication of KR20170005806A publication Critical patent/KR20170005806A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y10S514/8995—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
KR1020167031451A 2014-05-20 2015-05-20 신생아 마이크로바이옴 보충 Withdrawn KR20170005806A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462000842P 2014-05-20 2014-05-20
US62/000,842 2014-05-20
PCT/EP2015/061181 WO2015177246A2 (en) 2014-05-20 2015-05-20 Neonatal microbiome supplementation

Publications (1)

Publication Number Publication Date
KR20170005806A true KR20170005806A (ko) 2017-01-16

Family

ID=53284210

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167031451A Withdrawn KR20170005806A (ko) 2014-05-20 2015-05-20 신생아 마이크로바이옴 보충

Country Status (9)

Country Link
US (1) US20170216375A1 (cg-RX-API-DMAC7.html)
EP (1) EP3145520A2 (cg-RX-API-DMAC7.html)
JP (1) JP2017515881A (cg-RX-API-DMAC7.html)
KR (1) KR20170005806A (cg-RX-API-DMAC7.html)
CN (1) CN106879253A (cg-RX-API-DMAC7.html)
AU (1) AU2015261869A1 (cg-RX-API-DMAC7.html)
CL (1) CL2016002732A1 (cg-RX-API-DMAC7.html)
MX (1) MX2016015153A (cg-RX-API-DMAC7.html)
WO (1) WO2015177246A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
AU2015340605B2 (en) 2014-10-29 2021-06-24 Biogaia Ab Use of L. reuteri for recovery of microbiota dysbiosis in early life
WO2019118984A2 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
ES2928223T3 (es) * 2018-07-24 2022-11-16 Biogaia Ab Selección y uso de bacterias de apoyo a la melatonina para reducir los cólicos infantiles
CN112739814B (zh) * 2018-07-24 2023-12-08 生命大地女神有限公司 使用能够增加腺苷水平的细菌菌株的治疗方法
WO2020028871A1 (en) * 2018-08-03 2020-02-06 Research Institute At Nationwide Children's Hospital Prenatal probiotic formulations
EP3846830A4 (en) 2018-09-05 2022-07-06 Solarea Bio, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
JP7662538B2 (ja) 2019-06-03 2025-04-15 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル 敗血症および壊死性腸炎誘発神経発達不全の予防のためのプレバイオティクス製剤
EP4436407A1 (en) 2021-11-22 2024-10-02 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities
US20250255909A1 (en) * 2022-04-14 2025-08-14 Washington University Prevotella copri formulations and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system

Also Published As

Publication number Publication date
WO2015177246A8 (en) 2016-01-14
CN106879253A (zh) 2017-06-20
US20170216375A1 (en) 2017-08-03
EP3145520A2 (en) 2017-03-29
WO2015177246A3 (en) 2016-03-03
CL2016002732A1 (es) 2017-04-28
WO2015177246A2 (en) 2015-11-26
AU2015261869A1 (en) 2016-11-17
JP2017515881A (ja) 2017-06-15
MX2016015153A (es) 2017-03-07

Similar Documents

Publication Publication Date Title
KR20170005806A (ko) 신생아 마이크로바이옴 보충
Taylor et al. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial
Dani et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants: a prospective double-blind study
Lenoir-Wijnkoop et al. Probiotic and prebiotic influence beyond the intestinal tract
MX2012011270A (es) Pienso para acondicionar la flora intestinal de terneras.
US20100166721A1 (en) Probotic compositions and uses thereof
US11274275B2 (en) Lactobacillus paracasei ET-22 and use thereof
PL189998B1 (pl) Zastosowanie szczepu Lactobacillus Reuteri
AU2016353091A1 (en) Probiotic delivery systems
TW200305370A (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
CN102333534B (zh) 用于治疗胃溃疡和十二指肠溃疡的包括质子泵抑制剂及益生元的药物组合物
CN115068591B (zh) 一种包含骨桥蛋白的益生菌组合物
JP2018184481A (ja) 機能性消化管障害予防及び／又は改善剤
US20240307465A1 (en) Methods of preventing, delaying or ameliorating atopic diseases
Herman et al. Prevention of IgE-mediated food allergy: emerging strategies through maternal and neonatal interventions
JP2022504185A (ja) 細菌株を含む組成物
WO2022161928A1 (en) Probiotic composition comprising lactobacillus salivarius and bifidobacterium longum and its uses
RU2577994C1 (ru) Реутерин-вырабатывающие lactobacillus brevis
WO2011107960A1 (en) Compositions comprising lactobacillus mucosae for medical use
CN113840633A (zh) 凝结芽孢杆菌和枯草芽孢杆菌用于预防和治疗功能性胃肠道病症
CN113841737A (zh) 一株母乳来源罗伊氏乳杆菌防治特应性皮炎的应用
Crane Pro and anti: the biotics of allergic disease
TW201505641A (zh) 含益生菌之口服再水合溶液組成物
RU2203076C1 (ru) Способ лечения и профилактики желудочно-кишечных болезней телят
JP2021511822A (ja) 新規ラクトバチルス・サリバリウス株を含む組成物、及び中耳炎と上気道感染症の予防法／治療法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20161110

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination